Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.5 EUR | +1.35% | -1.10% | -16.04% |
May. 15 | BASTIDE LE CONFORT MEDICAL : De facto maintained guidance; more disposals to propel debt reduction | |
May. 15 | Bastide: 8.2% increase in quarterly sales | CF |
Sales 2024 * | 529M 575M | Sales 2025 * | 560M 608M | Capitalization | 164M 179M |
---|---|---|---|---|---|
Net income 2024 * | 16M 17.38M | Net income 2025 * | 22M 23.9M | EV / Sales 2024 * | 0.94 x |
Net Debt 2024 * | 333M 362M | Net Debt 2025 * | 328M 356M | EV / Sales 2025 * | 0.88 x |
P/E ratio 2024 * |
9.72
x | P/E ratio 2025 * |
7.19
x | Employees | 3,635 |
Yield 2024 * |
2.12% | Yield 2025 * |
2.59% | Free-Float | 44.91% |
1 day | +1.35% | ||
1 week | -1.10% | ||
Current month | +4.17% | ||
1 month | +13.52% | ||
3 months | +22.42% | ||
6 months | -10.00% | ||
Current year | -16.04% |
Managers | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Corporate Officer/Principal | 50 | 15-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vincent Bastide
CEO | Chief Executive Officer | 54 | 97-12-28 |
Vanessa Giraud
BRD | Director/Board Member | 50 | - |
Olivier Mares
BRD | Director/Board Member | 47 | 19-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 22.5 | +1.35% | 3 206 |
24-06-04 | 22.2 | 0.00% | 5,161 |
24-06-03 | 22.2 | +2.78% | 13,044 |
24-05-31 | 21.6 | -3.14% | 4,483 |
24-05-30 | 22.3 | -1.98% | 9,075 |
Real-time Euronext Paris, June 05, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.04% | 179M | |
-3.44% | 3.01B | |
0.00% | 1.97B | |
+22.83% | 1.84B | |
-11.98% | 451M | |
-49.66% | 291M | |
-16.05% | 135M | |
+1.92% | 67.84M |
- Stock Market
- Equities
- BLC Stock